Psychoneuroendocrinology
Volume 33, Issue 8 , Pages 1069-1076 , September 2008

Blocking NMDA receptor signaling does not decrease hormonal counterregulation to hypoglycemia in humans

  • Isabel Pais

      Affiliations

    • Department of Internal Medicine I, University of Luebeck, Ratzeburger Allee 160, 23538 Luebeck, Germany
    • Corresponding Author InformationCorresponding author. Tel.: +49 451 500 6407; fax: +49 451 500 4807.
    • ,
  • Christian Hubold

      Affiliations

    • Department of Internal Medicine I, University of Luebeck, Ratzeburger Allee 160, 23538 Luebeck, Germany
    • ,
  • Manfred Hallschmid

      Affiliations

    • Department of Neuroendocrinology, University of Luebeck, Luebeck, Germany
    • ,
  • Sebastian Letterer

      Affiliations

    • Department of Internal Medicine I, University of Luebeck, Ratzeburger Allee 160, 23538 Luebeck, Germany
    • ,
  • Kerstin Oltmanns

      Affiliations

    • Department of Internal Medicine I, University of Luebeck, Ratzeburger Allee 160, 23538 Luebeck, Germany
    • ,
  • Bernd Schultes

      Affiliations

    • Department of Internal Medicine I, University of Luebeck, Ratzeburger Allee 160, 23538 Luebeck, Germany
    • Interdisciplinary Obesity Centre, Kantonsspital St. Gallen, Heidenerstr. 11, 9400 Rorschach, Switzerland
    • ,
  • Jan Born

      Affiliations

    • Department of Neuroendocrinology, University of Luebeck, Luebeck, Germany
    • ,
  • Achim Peters

      Affiliations

    • Department of Internal Medicine I, University of Luebeck, Ratzeburger Allee 160, 23538 Luebeck, Germany

Received 18 September 2007 ,Revised 23 April 2008 ,Accepted 26 April 2008.

References 

  1. Adams HA, Thiel A, Jung A, Fengler G, Hempelmann G. Studies using S-(+)-ketamine on probands. Endocrine and circulatory reactions, recovery and dream experiences. Anaesthesist. 1992;41(10):588–596
  2. Amiel SA. Counterregulation to hypoglycaemia: physiology. Ann. Endocrinol. (Paris). 2004;65(1):85–87
  3. Bertrand G, Gross R, Puech R, Loubatières-Mariani MM, Bockaert J. Glutamate stimulates glucagon secretion via an excitatory amino acid receptor of the AMPA subtype in rat pancreas. Eur. J. Pharmacol. 1993;237(1):45–50
  4. Bradbury MJ, Giracello DR, Chapman DF, Holtz G, Schaffhauser H, Rao SP, et al. Metabotropic glutamate receptor 5 antagonist-induced stimulation of hypothalamic-pituitary-adrenal axis activity: interaction with serotonergic systems. Neuropharmacology. 2003;44(5):562–572
  5. Brann DW. Glutamate: a major excitatory transmitter in neuroendocrine regulation. Neuroendocrinology. 1995;61(3):213–225
  6. Broadbear JH, Winger G, Woods JH. Self-administration of fentanyl, cocaine and ketamine: effects on the pituitary-adrenal axis in rhesus monkeys. Psychopharmacology (Berl). 2004;176(3/4):398–406
  7. Cox DJ, Gonder-Frederick L, Antoun B, Cryer PE, Clarke WL. Perceived symptoms in the recognition of hypoglycemia. Diabetes Care. 1993;16(2):519–527
  8. Darlington DN, Miyamoto M, Keil LC, Dallman MF. Paraventricular stimulation with glutamate elicits bradycardia and pituitary responses. Am. J. Physiol. 1989;256(1 Pt 2):R112–R119
  9. Deary IJ, Hepburn DA, MacLeod KM, Frier BM. Partitioning the symptoms of hypoglycaemia using multi-sample confirmatory factor analysis. Diabetologia. 1993;36(8):771–777
  10. Dinse HR, Ragert P, Pleger B, Schwenkreis P, Tegenthoff M. Pharmacological modulation of perceptual learning and associated cortical reorganization. Science. 2003;301(5629):91–94
  11. Elvidge H, Challis JR, Robinson JS, Roper C, Thorburn GD. Influence of handling and sedation on plasma cortisol in rhesus monkeys (Macaca mulatta). J. Endocrinol. 1976;70(2):325–326
  12. Farah JM, Rao TS, Mick SJ, Coyne KE, Iyengar S. N-Methyl-d-aspartate treatment increases circulating adrenocorticotropin and luteinizing hormone in the rat. Endocrinology. 1991;128(4):1875–1880
  13. Gay VL, Plant TM. N-Methyl-d,l-aspartate elicits hypothalamic gonadotropin-releasing hormone release in prepubertal male rhesus monkeys (Macaca mulatta). Endocrinology. 1987;120(6):2289–2296
  14. Gerich JE, Mokan M, Veneman T, Korytkowski M, Mitrakou A. Hypoglycemia unawareness. Endocr. Rev. 1991;12(4):356–371
  15. Iyengar S, Mick S, Dilworth V, Michel J, Rao TS, Farah JM, et al. Sigma receptors modulate the hypothalamic–pituitary–adrenal (HPA) axis centrally: evidence for a functional interaction with NMDA receptors, in vivo. Neuropharmacology. 1990;29(3):299–303
  16. Jezova D, Tokarev D, Rusnak M. Endogenous excitatory amino acids are involved in stress-induced adrenocorticotropin and catecholamine release. Neuroendocrinology. 1995;62(4):326–332
  17. Kim DH, Moon YS, Jung JS, Suh HW, Song DK. Route-dependent effects of the non-NMDA receptor antagonist CNQX on plasma corticosterone levels in mice. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2003;27(6):1055–1058
  18. Kornhuber J, Quack G. Cerebrospinal fluid and serum concentrations of the N-methyl-d-aspartate (NMDA) receptor antagonist memantine in man. Neurosci. Lett. 1995;195(2):137–139
  19. Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD, et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch. Gen. Psychiatry. 1994;51(3):199–214
  20. Lipton SA. The molecular basis of memantine action in Alzheimer's disease and other neurologic disorders: low-affinity, uncompetitive antagonism. Curr. Alzheimer Res. 2005;2(2):155–165
  21. Meeker RB, Greenwood RS, Hayward JN. Glutamate receptors in the rat hypothalamus and pituitary. Endocrinology. 1994;134(2):621–629
  22. Molina PE, Abumrad NN. Contribution of excitatory amino acids to hypoglycemic counter-regulation. Brain Res. 2001;899(1/2):201–208
  23. Nakanishi S. Molecular diversity of the glutamate receptors. Clin. Neuropharmacol. 1992;15(Suppl. 1 Pt A):4A–5A
  24. Parsons CG, Stoffler A, Danysz W. Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system—too little activation is bad, too much is even worse. Neuropharmacology. 2007;53(6):699–723
  25. Peters A, Schweiger U, Pellerin L, Hubold C, Oltmanns KM, Conrad M, et al. The selfish brain: competition for energy resources. Neurosci. Biobehav. Rev. 2004;28(2):143–180
  26. Porter RH, Greenamyre JT. Regional variations in the pharmacology of NMDA receptor channel blockers: implications for therapeutic potential. J. Neurochem. 1995;64(2):614–623
  27. Reisberg B, Doody R, Stoffler A, Schmitt F, Ferris S, Mobius HJ. Memantine in moderate-to-severe Alzheimer's disease. N. Engl. J Med. 2003;348(14):1333–1341
  28. Reyes A, Luckhaus J, Ferin M. Unexpected inhibitory action of N-methyl-d,l-aspartate or luteinizing hormone release in adult ovariectomized rhesus monkeys: a role of the hypothalamic–adrenal axis. Endocrinology. 1990;127(2):724–729
  29. Sandberg M, Butcher SP, Hagberg H. Extracellular overflow of neuroactive amino acids during severe insulin-induced hypoglycemia: in vivo dialysis of the rat hippocampus. J. Neurochem. 1986;47(1):178–184
  30. Schugens MM, Egerter R, Daum I, Schepelmann K, Klockgether T, Loschmann PA. The NMDA antagonist memantine impairs classical eyeblink conditioning in humans. Neurosci. Lett. 1997;224(1):57–60
  31. Schwenkreis P, Witscher K, Pleger B, Malin JP, Tegenthoff M. The NMDA antagonist memantine affects training induced motor cortex plasticity—a study using transcranial magnetic stimulation [ISRCTN65784760]. BMC Neurosci. 2005;6(1):35
  32. Setchell KD, Shackleton CH, Himsworth RL. Studies on plasma corticosteroids in the rhesus monkey (Macaca mulatta). J. Endocrinol. 1975;67(2):241–250
  33. Taborsky GJ, Ahrén B, Havel PJ. Autonomic mediation of glucagon secretion during hypoglycemia: implications for impaired alpha-cell responses in type 1 diabetes. Diabetes. 1998;47(7):995–1005
  34. Tokarev D, Jezova D. Effect of central administration of the non-NMDA receptor antagonist DNQX on ACTH and corticosterone release before and during immobilization stress. Methods Find. Exp. Clin. Pharmacol. 1997;19(5):323–328
  35. Veneman T, Mitrakou A, Mokan M, Cryer P, Gerich J. Induction of hypoglycemia unawareness by asymptomatic nocturnal hypoglycemia. Diabetes. 1993;42(9):1233–1237
  36. Yousef KA, Tepper PG, Molina PE, Abumrad NN, Lang CH. Differential control of glucoregulatory hormone response and glucose metabolism by NMDA and kainate. Brain Res. 1994;634(1):131–140
  37. Zelena D, Mergl Z, Makara GB. Glutamate agonists activate the hypothalamic–pituitary–adrenal axis through hypothalamic paraventricular nucleus but not through vasopressinerg neurons. Brain Res. 2005;1031(2):185–193
  38. Zhou Y, Yuferov VP, Spangler R, Maggos CE, Ho A, Kreek MJ. Effects of memantine alone and with acute ‘binge’ cocaine on hypothalamic–pituitary–adrenal activity in the rat. Eur. J. Pharmacol. 1998;352(1):65–71

PII: S0306-4530(08)00130-3

doi: 10.1016/j.psyneuen.2008.04.002

Psychoneuroendocrinology
Volume 33, Issue 8 , Pages 1069-1076 , September 2008

Article Tools

* Image Usage & Resolution